Literature DB >> 33947925

Atypical electrophysiological and behavioral responses to diazepam in a leading mouse model of Down syndrome.

Daniella B Victorino1,2, Daniel J L L Pinheiro1, Jonah J Scott-McKean2, Sarah Barker2, Melissa R Stasko2, Jean Faber1, Carla A Scorza1, Alberto C S Costa3,4.   

Abstract

Mounting evidence implicates dysfunctional GABAAR-mediated neurotransmission as one of the underlying causes of learning and memory deficits observed in the Ts65Dn mouse model of Down syndrome (DS). The specific origin and nature of such dysfunction is still under investigation, which is an issue with practical consequences to preclinical and clinical research, as well as to the care of individuals with DS and anxiety disorder or those experiencing seizures in emergency room settings. Here, we investigated the effects of GABAAR positive allosteric modulation (PAM) by diazepam on brain activity, synaptic plasticity, and behavior in Ts65Dn mice. We found Ts65Dn mice to be less sensitive to diazepam, as assessed by electroencephalography, long-term potentiation, and elevated plus-maze. Still, diazepam pre-treatment displayed typical effectiveness in reducing susceptibility and severity to picrotoxin-induced seizures in Ts65Dn mice. These findings fill an important gap in the understanding of GABAergic function in a key model of DS.

Entities:  

Year:  2021        PMID: 33947925     DOI: 10.1038/s41598-021-89011-y

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  63 in total

Review 1.  Down's syndrome: a genetic disorder in biobehavioral perspective.

Authors:  L Nadel
Journal:  Genes Brain Behav       Date:  2003-06       Impact factor: 3.449

2.  Myoclonic epilepsy in Down syndrome and Alzheimer disease.

Authors:  J S Aller-Alvarez; M Menéndez-González; R Ribacoba-Montero; M Salvado; V Vega; R Suárez-Moro; M Sueiras; M Toledo; J Salas-Puig; J Álvarez-Sabin
Journal:  Neurologia       Date:  2015-02-07       Impact factor: 3.109

3.  Epilepsy in adult patients with Down syndrome: a clinical-video EEG study.

Authors:  Aglaia Vignoli; Elena Zambrelli; Valentina Chiesa; Miriam Savini; Francesca La Briola; Elena Gardella; Maria Paola Canevini
Journal:  Epileptic Disord       Date:  2011-06       Impact factor: 1.819

4.  Deficits in hippocampal CA1 LTP induced by TBS but not HFS in the Ts65Dn mouse: a model of Down syndrome.

Authors:  Alberto C S Costa; Michael J Grybko
Journal:  Neurosci Lett       Date:  2005-04-12       Impact factor: 3.046

Review 5.  Prevalence of epilepsy among people with intellectual disabilities: A systematic review.

Authors:  Janet Robertson; Chris Hatton; Eric Emerson; Susannah Baines
Journal:  Seizure       Date:  2015-03-30       Impact factor: 3.184

Review 6.  Epilepsy in children with Down syndrome.

Authors:  Ravindra Arya; Madhulika Kabra; Sheffali Gulati
Journal:  Epileptic Disord       Date:  2011-03       Impact factor: 1.819

7.  Neurodevelopmental and psychiatric issues in Down's syndrome: assessment and intervention.

Authors:  Stefano Vicari; Maria Pontillo; Marco Armando
Journal:  Psychiatr Genet       Date:  2013-06       Impact factor: 2.458

8.  Hippocampal long-term potentiation suppressed by increased inhibition in the Ts65Dn mouse, a genetic model of Down syndrome.

Authors:  Alexander M Kleschevnikov; Pavel V Belichenko; Angela J Villar; Charles J Epstein; Robert C Malenka; William C Mobley
Journal:  J Neurosci       Date:  2004-09-15       Impact factor: 6.167

9.  Pharmacological Modulation of Three Modalities of CA1 Hippocampal Long-Term Potentiation in the Ts65Dn Mouse Model of Down Syndrome.

Authors:  Jonah J Scott-McKean; Adriano L Roque; Krystyna Surewicz; Mark W Johnson; Witold K Surewicz; Alberto C S Costa
Journal:  Neural Plast       Date:  2018-04-10       Impact factor: 3.599

10.  National population-based estimates for major birth defects, 2010-2014.

Authors:  Cara T Mai; Jennifer L Isenburg; Mark A Canfield; Robert E Meyer; Adolfo Correa; Clinton J Alverson; Philip J Lupo; Tiffany Riehle-Colarusso; Sook Ja Cho; Deepa Aggarwal; Russell S Kirby
Journal:  Birth Defects Res       Date:  2019-10-03       Impact factor: 2.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.